Mirador Capital Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-15,390
Closed -$215K 159
2018
Q2
$215K Buy
15,390
+77
+0.5% +$1.3K 0.12% 133
2018
Q1
$278K Buy
+15,313
New +$219K 0.19% 95

Other funds holding PGEN

Mirador Capital Partners's PGEN Position: Q3 2018 in Review

Mirador Capital Partners sold out of Precigen (PGEN) in Q3 2018, closing a stake of 15,390 shares — an estimated $215K sold.

Mirador Capital Partners first reported a position in PGEN in Q1 2018 and held it in 2 quarters. The position peaked at $278K in Q1 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.

  • Mirador Capital Partners reported no remaining Precigen position as of Q3 2018 after selling out during the quarter.
  • Mirador Capital Partners sold 15,390 Precigen shares in Q3 2018, an estimated $215K.
  • Mirador Capital Partners first reported a position in Precigen in Q1 2018 and held it in 2 quarters.
  • Mirador Capital Partners's Precigen position peaked at $278K in Q1 2018.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.

Based on Mirador Capital Partners's 13F filing for Q3 2018, filed 13 Nov 2018.